Credit Suisse’s Trillium Therapeutics Inc. TRIL Stock Holding History

Credit Suisse’s Portfolio TRIL Stock Details TRIL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell
2021 Q3	$5.53M	Buy
2021 Q2	$658K	Sell
2021 Q1	$932K	Buy
2020 Q4	$1.03M	Buy
2017 Q1	–	Sell
2016 Q4	$143K	Buy